Columbia Universtity Department of Neurology
Columbia University | Department of Neurology
> back to Neuropathy faculty & staff listing
Louis H. Weimer, MDLouis H. Weimer, MD
Co-Director, Columbia Neuropathy Research Center
Associate Clinical Professor of Neurology
Columbia University College of Physicians and Surgeons

Director, Autonomic Function Laboratory
Columbia University Medical Center
New York Presbyterian Hospital


Education
College: Emory University, Chemistry
MD: Emory College of Medicine
Residency: Columbia-Presbyterian Medical Center
Fellowship: Neurological Institute of NY at CPMC

Board Certification
American Board of Neurology and Psychiatry
American Board of Electrodiagnostic Medicine

Office Location
The Neurological Institute
710 W. 168th Street
Phone: 212 305 1516
Fax: 212 305 5396
Dr. Weimer is a full time faculty member of the EMG laboratory and additionally directs the Clinical autonomic laboratory [link to page]. His clinical and research interests include testing of autonomic and small nerve fiber function, dysautonomia, small fiber neuropathy, neurologic causes of syncope, and autonomic failure syndromes. Other special interests include neuropathy from medications and toxins, entrapment neuropathies, and the myopathy of critical illness. He coordinates the resident selective in neuromuscular disease and trains fellows in clinical neurophysiology. He has participated in numerous clinical trials of various neuromuscular disorders, including diabetic and HIV-related neuropathy, Lou Gehrig's disease, and others; he has published over 90 peer reviewed papers, invited reviews, book chapters, and meeting abstracts to date.

Dr. Weimer is the current chairman of the training program committee and member of CME accreditation committee for the American Association of Neuromuscular and Electrodiagnostic Medicine; he is on the national medical advisory board for the Charcot-Marie-Tooth Association; and is a frequent oral board examiner for the American Board of Electrodiagnostic Medicine. He is a senior editor of Medlink neurology and serves as the departmental chairman of the quality assurance and improvement committee.

In addition to autonomic and neuromuscular patient testing, Dr. Weimer sees select patients for an initial diagnostic consultation, in most instances patients with various forms of autonomic dysfunction.


Selected Recent Publications

  1. Weimer LH, Podwall D. Medication-induced exacerbation of neuropathy in Charcot Marie Tooth Disease. J Neurol Sci 2006;242:47-54.

  2. Gordon PH, Doorish C, Montes J, Mosley RL, Diamond B, Robert B, MacArthur RB, Weimer LH, Kaufmann P, Hays AP, Rowland LP, Gendelman H, Przedborski S, Mitsumoto H. Randomized Controlled Phase II Trial of Glatiramer Acetate (Copaxone) in Amyotrophic Lateral Sclerosis. Neurology 2006;66:1117-9.

  3. Etienne M, Weimer, LH. Immune-mediated autonomic neuropathies. [Invited review] Curr Neurol Neurosci Rep 2006;6:57-64.

  4. Weimer LH, Anziska Y. Metabolic, immune-mediated and toxic neuropathies. In Neurology: Basic and clinical neurosciences. Shapira A, ed. Philadelphia: Elsevier, 2006. [in press]

  5. Renaud S, Hays AP, Brannagan TH 3rd, Sander HW, Edgar M, Weimer LH, Olarte MR, Dalakas MC, Xiang Z, Danon MJ, Latov N. Gene expression profiling in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 2005;159:203-14.

  6. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Steven Heymsfield S, Gallagher D, Mayer L, Murphy E, Leibel RL. Low dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. J Clin Invest 2005;115:3579-86.

  7. Pratt RW, Weimer LH. Toxic and medication-induced peripheral neuropathy. [Invited review] Semin Neurol 2005;25:204-16.

  8. Goldfarb AR, Weimer LH, Brannagan TH. Rituximab treatment of an immunoglobulin M monoclonal autonomic and sensory neuropathy. Muscle Nerve 2005;31:510-5.

  9. Shy ME, Frohman EM, So YT, Arezzo JC, Cornblath DR, Giuliani MJ, Kincaid JC, Ochoa JL, Parry GJ, Weimer LH. Quantitative sensory testing: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2003;60:898-904.

  10. Weimer LH, Williams O. Syncope and orthostatic intolerance. [Invited review] Med Clin N Am 2003;87:835-865.

©1997-2006 The Neurological Institute of New York • At Columbia University Medical Center
Updated June 14, 2007
Comments